- €71.97bn
- €79.45bn
- €85.11bn
- 49
- 81
- 97
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 133,694 | 113,471 | 122,307 | 85,968 | 85,109 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 128,095 | 107,995 | 113,226 | 78,584 | 75,892 |
Operating Profit | 5,599 | 5,476 | 9,081 | 7,384 | 9,217 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,624 | 4,872 | 9,196 | 6,583 | 8,886 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,205 | 3,331 | 7,507 | 5,207 | 7,373 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,856 | 3,164 | 7,293 | 5,061 | 7,189 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,604 | 2,987 | 7,100 | 4,879 | 7,004 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.48 | 1.85 | 3.52 | 2.33 | 3.38 |
Dividends per Share |